Use of Mammographic Screening by HIV-Infected Women in the Women's Interagency HIV Study (WIHS)

doi:10.1006/pmed.2001.1003

Preventive Medicine

Volume 34, Issue 3, March 2002, Pages 386-392

https://doi.org/10.1006/pmed.2001.1003 Get rights and content

Abstract

Background. Although HIV-positive women may be less likely than women in general to receive mammography due to socioeconomic disadvantage, HIV diagnosis may increase opportunities for medical interactions which encourage mammography.

Methods. HIV-positive (2,059) and HIV-negative (569) Women's Interagency HIV Study (WIHS) participants reported ever/never history of mammography at baseline (in 1994, 1995) and, at each 6-month follow-up visit, if they had been screened since their last visit. National Health Interview Survey (NHIS) data for 1994 were used to compare WIHS participants to U.S. women. Factors independently related to mammography were determined using logistic regression for baseline data and proportional hazards for follow-up data. Results were adjusted for age.

Results. Among women ≥40, fewer WIHS women, regardless of HIV status, reported screening than U.S. women (67% HIV-positive, 62% HIV-negative, 79% NHIS; P < 0.0001). First-time screening while on study was associated with being HIV-positive [rate ratio (95% confidence interval) = 1.6 (1.1, 2.3)]. Factors independently associated with screening were related to health care access and usage.

Conclusions. WIHS women, a disadvantaged population, reported less mammography than the general population. HIV-positive women reported more screening than HIV-negative women, possibly because of greater opportunity to interact with the health care system.

References (38)

ZH Wu et al.
Prevalence and associated factors of cancer screening: Why are so many older Mexican American women never screened?
Prev Med
(2001)
J Camirand et al.
Pap recency: modeling women's characteristics and their patterns of medical care use
Prev Med
(1995)
L Suarez et al.
Knowledge, behavior, and fears concerning breast and cervical cancer among older low-income Mexican-American women
Am J Prev Med
(1997)
DN Pearlman et al.
Breast cancer screening practices among black, Hispanic, and white women: reassessing differences
Am J Prev Med
(1996)
HB Hedegaard et al.
Factors associated with screening mammography in low-income women
Am J Prev Med
(1996)
BD McCarthy et al.
Screening mammography use: The importance of a population perspective
Am J Prev Med
(1996)
PG McGovern et al.
Accuracy of self-report of mammography and Pap smear in a low-income urban population
Am J Prev Med
(1998)
VA Lawrence et al.
Systematic differences in validity of self-reported mammography behavior: a problem for intergroup comparisons
Prev Med
(1999)
American Cancer Society, American Cancer Society Statement on Mammography Guidelines, 1/23/97 (online). Available at,...
National Institutes of Health, National Cancer Institute, NIH News Release: National Cancer Advisory Board Issues...

U.S. Department of Health and Human Services, Healthy People 2000. National health promotion and disease prevention...

SJ McPhee et al.

Factors associated with breast and cervical cancer screening practices among Vietnamese American women

Cancer Detect Prevent

(1997)

NP Peragallo et al.

Breast care among Latino immigrant women in the US

Health Care Women Int

(1998)

KP Derose et al.

Church-based telephone mammography counseling with peer counselors

J Health Comm

(2000)

N Duan et al.

Maintaining mammography adherence through telephone counseling in a church-based trial

Am J Public Health

(2000)

M Kagawa-Singer et al.

Asian American and Pacific Islander breast and cervical carcinoma screening rates and healthy people 2000 objectives

Cancer

(2000)

SP Tu et al.

Breast cancer screening among Cambodian American women

Cancer Detect Prev

(2000)

N Breen et al.

Progress in cancer screening over a decade: results of cancer screening from the 1987, 1992 and 1998 National Health Interview Surveys

JNCI

(2001)

Cited by (28)

The epidemiology of cancers in human immunodeficiency virus infection and after organ transplantation
2015, Seminars in Oncology
Citation Excerpt :
Studies from early in the HIV epidemic described a decreased incidence of breast cancer compared to the general population, but the incidence has increased towards that of the general population in more recent years.103 A potential explanation for that pattern is that prior to effective anti-retroviral therapy, women received less breast cancer screening,37 and that with prolonged survival screening rates are likely to have increased. In the United States, incidence rates of breast cancer in women with HIV remained constant between 1996 and 2010.22
The authors provide an update on the association between immune deficiency and cancer risk in people with human immunodeficiency virus (HIV) and in solid organ transplant recipients. Over the past decade, it has become clear that a wider range of about 20 mostly infection-related cancers occur at increased rates in people with immune deficiency. The human herpes virus 8 (HHV8) and Epstein Barr Virus (EBV)-related cancers of Kaposi sarcoma (KS) and non-Hodgkin lymphoma (NHL) are most closely related to level of immune deficiency. Transplant recipients also have a greatly increased risk of squamous cell carcinoma (SCC) of the skin, related to direct carcinogenic effects of the pharmaceuticals used for immune suppression. For those three cancer types, the increased cancer risk is largely reversed when immune deficiency is decreased by treatment of HIV or by reduction of iatrogenic immune suppression. Other infection-related cancers also occur at increased rates, but it is not clear whether reduction of immune deficiency reduces cancer risk. Prostate and breast cancer do not occur at increased rates, providing strong evidence that these cancers are unlikely to be related to infection. Epidemiological and clinical trends in these two populations have led to substantial recent changes in cancer occurrence.
Breast cancer in a cohort of human immunodeficiency virus (HIV)-infected women from Rio de Janeiro, Brazil: A cases series report and an incidence rate estimate
2011, Brazilian Journal of Infectious Diseases
Highly active antiretroviral therapy (HAART) has changed the morbidity pattern affecting HIV-infected individuals to include non-AIDS-defining cancers. We describe the breast cancer cases occurring in a cohort of 860 HIV-infected women followed in Rio de Janeiro, Brazil, and estimate the incidence rate of breast cancer for this population. Nine cases were identified; median age at diagnosis was 46 years. Median survival after breast cancer diagnosis was 12 months. Breast cancer diagnosis was made within 2 to 15 years of HIV-infection diagnosis. At breast cancer diagnosis, CD4 counts ranged from 135 to 782 cells/mm³; six women were receiving HAART. Histological analysis indicated infiltrating ductal carcinoma in all cases. The incidence rate of breast cancer was 133 cases per 100,000 persons-year. Patients from our case series were late diagnosed with breast cancer and thus suffered from worse prognosis. Strategies targeting earlier diagnosis and prompt initiation of treatment are needed.
Non-AIDS-defining cancers in the light of recent research
2010, HIV and AIDS Review
The results of the recent research which shows twice as high risk of non-AIDS-defining cancers among people diagnosed with AIDS in relation to the general population, make us look for the reasons of this phenomenon. What is taken into consideration are the following: the influence of factors other than HIV, decreased immunity during infection and the direct influence of the antiretroviral therapy on the development of cancerous processes.
Secular Trends in Breast Cancer Risk Among Women With HIV Initiating ART in North America
2021, Journal of Acquired Immune Deficiency Syndromes
Cancer Incidence and Cancer Screening Practices Among a Cohort of Persons Receiving HIV Care in Washington, DC
2021, Journal of Community Health
Cancer disparities in people with HIV: A systematic review of screening for non-AIDS–defining malignancies
2019, Cancer

View all citing articles on Scopus

^☆: This work was funded by the National Institute of Allergy and Infectious Diseases, with additional supplemental funding from the National Cancer Institute, the National Institute of Child Health and Human Development, the National Institute on Drug Abuse, the National Institute of Dental Research, the Agency for Health Care Policy and Research, and the Centers for Disease Control and Prevention, Contract Nos. U01-AI-35004, U01-AI-31834, U01-AI-34994, AI-34989, U01-HD-32632 (NICHD), U01-AI-34993, U01-AI-42590, and N01-AI-35161.

²: To whom correspondence and reprint requests should be addressed at Keck School of Medicine, University of Southern California/Norris Comprehensive Cancer Center, Department of Preventive Medicine, 1441 Eastlake Avenue, MS 44, Suites 4411/4415, P.O. Box 33800, Los Angeles, CA 90033-0800. Fax: (323) 865-0428. E-mail: [email protected].

View full text

Regular ArticleUse of Mammographic Screening by HIV-Infected Women in the Women's Interagency HIV Study (WIHS)☆

Abstract

Prev Med

Prev Med

Am J Prev Med

Am J Prev Med

Am J Prev Med

Am J Prev Med

Am J Prev Med

Prev Med

Factors associated with breast and cervical cancer screening practices among Vietnamese American women

Cancer Detect Prevent

Breast care among Latino immigrant women in the US

Health Care Women Int

Church-based telephone mammography counseling with peer counselors

J Health Comm

Maintaining mammography adherence through telephone counseling in a church-based trial

Am J Public Health

Asian American and Pacific Islander breast and cervical carcinoma screening rates and healthy people 2000 objectives

Cancer

Breast cancer screening among Cambodian American women

Cancer Detect Prev

Progress in cancer screening over a decade: results of cancer screening from the 1987, 1992 and 1998 National Health Interview Surveys

JNCI

Regular Article
Use of Mammographic Screening by HIV-Infected Women in the Women's Interagency HIV Study (WIHS)☆